![](https://news.alnylam.com/sites/default/files/user-media/images/banners/banner-sm.jpeg)
Posts By: John Maraganore, Ph.D.
February 28, 2018
RNAi Therapeutics: From Eureka! Moment to a Potential New Class of Medicines
How far science and technology have come! At Alnylam, we believe we’re on the verge of a landmark moment in medicine and I can’t help but express my...
Read More ›
September 2, 2019
ORION-11: A Landmark Event for RNAi Therapeutics
The results from the ORION-11 Phase 3 study of inclisiran, presented earlier today at the European Society of Cardiology meeting represent a landmark event...
Read More ›
April 11, 2019
Letter to the Editor: Federal Research is Important, but Companies Turn it Into Actual Tre ...
John Maraganore wrote a Letter to the Editor in The Washington Post about the importance of federal research...
Read More ›
![](/sites/default/files/2019-04/Category_RNAi.png)
![](/sites/default/files/2019-07/WAPO%20Replacement%20Hero%20Image.png)